Tolerant and diverse natural killer cell repertoires in the absence of selection

Experimental Cell Research

Volumn 316, Issue 8, 2010, Pages 1309-1315

  Andersson, Sandra ^a   Malmberg, Jenny Ann ^a   Malmberg, Karl Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Education; Killer cell immunoglobulin like receptors; Natural killer cells; Selection; Tolerance

Indexed keywords

CD94 ANTIGEN; CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D;

CELLULAR IMMUNITY; CYTOTOXICITY; HUMAN; LYMPHOCYTE FUNCTION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; ANIMAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; RECEPTORS, KIR;

EID: 77952563075     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.030     Document Type: Review

References (46)

1. Herberman R.B., Nunn M.E., Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 1975, 16:216-229.
2. Kiessling R., Klein E., Wigzell H. Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 1975, 5:112-117.
3. Stern P., Gidlund M., Orn A., Wigzell H. Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC. Nature 1980, 285:341-342.
4. Kiessling R., Hochman P.S., Haller O., Shearer G.M., Wigzell H., Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 1977, 7:655-663.
5. Cudkowicz G., Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J. Exp. Med. 1971, 134:1513-1528.
6. Karre K. Natural killer cell recognition of missing self. Nat. Immunol. 2008, 9:477-480.
7. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319:675-678.
8. Ljunggren H.G., Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 1985, 162:1745-1759.
9. Ljunggren H.G., Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990, 11:237-244.
10. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 2006, 214:73-91.
11. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
12. Moretta A., Vitale M., Bottino C., Orengo A.M., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993, 178:597-604.
13. Karlhofer F.M., Ribaudo R.K., Yokoyama W.M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992, 358:66-70.
14. Ljunggren H.G., Malmberg K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 2007, 7:329-339.
15. Wende H., Colonna M., Ziegler A., Volz A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm. Genome 1999, 10:154-160.
16. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 2005, 5:201-214.
17. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 1998, 188:1841-1848.
18. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799.
19. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751.
20. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., Romagne F., Ugolini S., Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
21. Brennan J., Mager D., Jefferies W., Takei F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 1994, 180:2287-2295.
22. Raulet D.H., Held W., Correa I., Dorfman J.R., Wu M.F., Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 1997, 155:41-52.
23. Held W., Dorfman J.R., Wu M.F., Raulet D.H. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 1996, 26:2286-2292.
24. Roth C., Carlyle J.R., Takizawa H., Raulet D.H. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 2000, 13:143-153.
25. Hanke T., Takizawa H., Raulet D.H. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur. J. Immunol. 2001, 31:3370-3379.
26. Dorfman J.R., Raulet D.H. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 1998, 187:609-618.
27. Gumperz J.E., Valiante N.M., Parham P., Lanier L.L., Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J. Exp. Med. 1996, 183:1817-1827.
28. Frohn C., Schlenke P., Kirchner H. The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology 1997, 92:567-570.
29. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 2006, 203:633-645.
30. Shilling H.G., Young N., Guethlein L.A., Cheng N.W., Gardiner C.M., Tyan D., Parham P. Genetic control of human NK cell repertoire. J. Immunol. 2002, 169:239-247.
31. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003, 101:3730-3740.
32. Andersson S., Fauriat C., Malmberg J.A., Ljunggren H.G., Malmberg K.J. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009, 114(1):95-104.
33. Yawata M., Yawata N., Draghi M., Partheniou F., Little A.M., Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK cell repertoires towards a balance of missing-self response. Blood 2008, 112(6):2369-2380.
34. Joncker N.T., Raulet D.H. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 2008, 224:85-97.
35. Brodin P., Lakshmikanth T., Johansson S., Karre K., Hoglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009, 113(11):2434-2441.
36. Fauriat C., Andersson S., Bjorklund A.T., Carlsten M., Schaffer M., Bjorkstrom N.K., Baumann B.C., Michaelsson J., Ljunggren H.G., Malmberg K.J. Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J. Immunol. 2008, 181:6010-6019.
37. Cooley S., Miller J.S. "Self"-reflection by KIR. Blood 2009, 114:2-3.
38. Fauriat C., Ivarsson M.A., Ljunggren H.G., Malmberg K.J., Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 2010, 115(6):1166-1174.
39. Cooley S., Xiao F., Pitt M., Gleason M., McCullar V., Bergemann T.L., McQueen K.L., Guethlein L.A., Parham P., Miller J.S. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 2007, 110:578-586.
40. Bjorklund A.T., Schaffer M., Fauriat C., Ringden O., Remberger M., Hammarstedt C., Barrett A.J., Ljungman P., Ljunggren H.G., Malmberg K.J. NK cells expressing inhibitory KIR for non-self ligands remain tolerant in HLA-matched sibling stem cell transplantation. Blood 2010, (Jan 22, Electronic publication ahead of print).
41. Uhrberg M. Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol. Immunol. 2005, 42:471-475.
42. Santourlidis S., Graffmann N., Christ J., Uhrberg M. Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. J. Immunol. 2008, 180:418-425.
43. Li H., Pascal V., Martin M.P., Carrington M., Anderson S.K. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet. 2008, 4:e1000254.
44. Pascal V., Stulberg M.J., Anderson S.K. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!. Immunol. Rev. 2006, 214:9-21.
45. Davies G.E., Locke S.M., Wright P.W., Li H., Hanson R.J., Miller J.S., Anderson S.K. Identification of bidirectional promoters in the human KIR genes. Genes Immun. 2007, 8:245-253.
46. Parham P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin. Immunol. 2008, 20:311-316.